This is a condition where muscles don't relax properly after you use them. It can make muscles feel stiff or hard to move. It's a sign of certain muscle diseases.
Every report comes from a Lived member, sent anonymously.
Have you tried Lamictal (Lamotrigine) for Myotonia?
Myotonia is a delay in a muscle's ability to relax after it has tightened. A person may grip a door handle and find their fingers slow to let go, squeeze their eyes shut and struggle to open them again, or stand up after sitting and feel their legs stiff and awkward for the first few steps. This is not an ordinary cramp from overuse. The muscle's outer membrane is electrically overexcitable, so the muscle keeps firing after the signal to contract has stopped. Myotonia is a sign rather than a diagnosis in itself. It is the hallmark of two groups of inherited conditions. The myotonic dystrophies (types 1 and 2) are whole-body diseases in which myotonia comes with gradually progressive muscle weakness and can involve the heart, eyes and hormones. The non-dystrophic myotonias, mainly myotonia congenita and paramyotonia congenita, affect skeletal muscle only. Knowing which condition lies behind the stiffness matters more than the stiffness itself, because it decides the outlook, the monitoring and the treatment. How the stiffness behaves offers clues. In myotonia congenita, it is worst when moving after rest and eases with repeated movement, which is called the warm-up effect. In paramyotonia congenita, stiffness worsens with cold and with continued activity, and prolonged cold can bring episodes of weakness lasting hours.
Most myotonia is inherited. Myotonia congenita comes from changes in the CLCN1 gene, which builds a chloride channel that normally steadies the muscle's electrical charge. It can be passed on in a dominant pattern (Thomsen disease, where one altered copy is enough and a parent is usually affected) or a recessive pattern (Becker disease, where a person inherits an altered copy from each parent, and the parents usually have no symptoms). Paramyotonia congenita and a related, less common form called sodium channel myotonia come from changes in the SCN4A gene, which builds a sodium channel, and are inherited in a dominant pattern. Myotonic dystrophy is caused by an abnormally long repeated stretch of genetic code in one of two genes, a different gene for each type. Myotonia can also appear on testing in some other muscle diseases, including Pompe disease (an inherited metabolic muscle disease) and certain toxic or autoimmune muscle conditions, and very rarely a medicine causes it. Causes are different from the things that bring on stiffness in someone who already has myotonia. Common triggers are moving after a period of rest and sudden forceful effort. In the sodium channel conditions, cold is a strong trigger, and some people notice worse symptoms after a high potassium intake.
Diagnosis starts with the history of the stiffness: when it began, which muscles it affects, whether it eases or worsens with repeated movement or cold, and whether relatives have similar symptoms. On examination, a clinician may ask the person to grip tightly and let go quickly, or to close the eyes hard and open them, watching for slow release. Tapping a muscle with a reflex hammer can produce a brief locked contraction, called percussion myotonia. Needle electromyography (EMG), a test that records electrical activity inside muscles through a fine needle, shows a characteristic pattern of repeated discharges that change in speed and size. This confirms that myotonia is present, although similar discharges occasionally appear in other muscle diseases. A blood test for creatine kinase, an enzyme released by damaged muscle, is often normal or only mildly raised in the channel conditions. Genetic testing usually identifies the responsible condition, either by targeted testing of the chloride and sodium channel genes or of the repeat that causes myotonic dystrophy, or through a broader muscle gene panel. A confirmed genetic diagnosis also helps relatives understand their own risk.
No treatment corrects the underlying gene change, but practical measures and medicines can reduce how much stiffness gets in the way. People with mild myotonia often manage without medicine by using the warm-up effect before demanding activity, avoiding cold when it is a trigger and allowing extra time to get going after rest. When stiffness, pain or falls interfere with daily life, mexiletine is usually the first medicine tried. It blocks sodium channels in muscle, calming the overexcitable membrane. It was developed as a heart rhythm medicine, and in the United States it is approved only for serious heart rhythm problems, so its use for myotonia is off-label, although it is the best-studied option. In trials in the non-dystrophic myotonias it reduced the stiffness people recorded in daily diaries and improved quality of life compared with a placebo, but not everyone responds. In myotonic dystrophy it shortened how long a grip took to release. Stomach upset, tiredness and headache are the common side effects. Because mexiletine can disturb heart rhythm in people with heart conduction disease, heart health is part of the decision. In myotonic dystrophy, mexiletine is generally avoided when the heart's conduction system is already affected. Otherwise, an electrocardiogram (ECG), a recording of the heart's electrical activity, is done before starting and repeated during treatment, often with a cardiologist involved. In the non-dystrophic myotonias, which do not affect the heart, trials and long-term follow-up have not shown meaningful ECG changes on mexiletine. Lamotrigine (Lamictal), an epilepsy medicine that also blocks sodium channels and is likewise used off-label for myotonia, is the other option with trial evidence and can suit people who cannot take mexiletine or do not benefit from it. In a direct comparison it helped but was not shown to work as well. Its dose is raised slowly because it can rarely cause a serious skin rash. Older medicines such as phenytoin (an older epilepsy medicine) and quinine (once widely used for leg cramps) have been tried, but trials have not shown a clear benefit. In myotonic dystrophy, easing myotonia is only one part of care, alongside managing weakness and the heart, breathing and other effects of the disease.
The course depends on the underlying condition. The non-dystrophic myotonias affect only skeletal muscle, and people have a normal life expectancy. Stiffness usually begins in childhood, sometimes first noticed as falls, trouble getting going after sitting, feeding difficulties, or eyelids that stay shut after crying. Severity ranges from barely noticeable to enough to interfere with walking, running and sport, and in myotonia congenita men tend to be more affected than women. Many people also live with muscle pain and fatigue. People with the Becker form often have brief weakness when they first start moving and may develop mild permanent weakness over time, and some people report that symptoms slowly worsen over the years. In myotonic dystrophy, myotonia is often not the main problem. Progressive weakness and the disease's effects on the heart, eyes, breathing and blood sugar shape daily life more, and regular follow-up includes heart checks such as a yearly ECG. Severity varies widely, even within one family. One practical point matters for anyone with a myotonic disorder. Some drugs used in anesthesia, particularly the muscle relaxant succinylcholine (also called suxamethonium), can set off severe muscle spasm and make breathing support difficult. Tell the surgical and anesthesia team about the diagnosis well before any operation or procedure that involves sedation or general anesthesia, so they can plan which drugs to use.
See a doctor, ideally a neurologist or neuromuscular specialist, if muscles are repeatedly slow to relax after gripping, blinking or starting to move, especially when similar stiffness runs in the family or comes with weakness. Arrange a review if stiffness, falls or pain start to limit work, school or exercise, or if a treatment is not helping or causes troublesome side effects. Report a new rash while taking lamotrigine to the prescriber right away. People with myotonic dystrophy should get same-day medical assessment for near-fainting, a racing or irregular heartbeat, chest pain or new breathlessness, because heart rhythm problems are part of that disease. Fainting, or chest pain that does not settle, needs emergency care, because in myotonic dystrophy passing out can signal a dangerous heart rhythm problem.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Myotonia is like, what's helped you, or ask the community a question.